All News #Library
Rare Diseases
BridgeBio company sells off rare disease candidate to Galderma partner
28 Jan 2023 //
ENDPTS
PellePharm readies hedgehog inhibitor for phase 3, plans series C after claiming
31 Jul 2017 //
FIERCE BIOTECH

Market Place
Sourcing Support